Hao Jiang

机构：Jilin University, Fudan University, Chinese PLA General Hospital, Zhejiang Hospital · ORCID：0000-0001-9590-9636

发表论文 40 篇 · 总被引 1735 次 · h-index 25

代表论文

• LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation (2018 · Biomedicine & Pharmacotherapy · 被引 177)
• Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer (2017 · Biomedicine & Pharmacotherapy · 被引 135)
• miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1 (2016 · Biomedicine & Pharmacotherapy · 被引 120)
• EZH2 promotes gastric cancer cells proliferation by repressing p21 expression (2019 · Pathology - Research and Practice · 被引 67)
• Exosomes derived from platelet-rich plasma activate YAP and promote the fibrogenic activity of Müller cells via the PI3K/Akt pathway (2020 · Experimental Eye Research · 被引 55)
• CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway (2020 · Frontiers in Oncology · 被引 54)